|
Summary
April 2008, Vol. 12, No. 4, Pages 505-515
, DOI 10.1517/14728222.12.4.505
The yeast two-hybrid system and its role in drug discoveryNicolas LentzeDualsystems Biotech AG, Grabenstrasse 11a, 8952 Schlieren, Switzerland +41 44 738 5000; +41 44 738 5005; auerbach@dualsystems.com Background: The yeast two-hybrid system is the most widely used genetic assay to identify and characterize novel protein interactions. Over the past decade, the system has been adapted to cover an increasingly wide range of applications, including various tasks within the drug discovery and development process. Objective: We highlight the role of different two-hybrid systems within the drug discovery process, including target identification and validation and the selection of affinity reagents for protein targets, such as peptides and small molecules. Methods: We have focused on applications where the two-hybrid system has been used to great advantage and have sought to put a special emphasis on less conventional but promising approaches, such as the identification of agents which block therapeutically relevant protein interactions. Conclusions: The yeast two-hybrid system has evolved from a method mainly used in basic research to a collection of versatile screening systems with the potential to affect many different aspects of drug discovery today. Forward Links to Citing ArticlesNathan C. Tedford, Amy B. Hall, James R. Graham, Cheryl E. Murphy, Neal F. Gordon, Jeffrey A. Radding. (2009) Quantitative analysis of cell signaling and drug action via mass spectrometry-based systems level phosphoproteomics. PROTEOMICS 9:6, 1469-1487 Online publication date: 1-Apr-2009. CrossRef Jürgen J Heinisch. (2008) Baker's yeast as a tool for the development of antifungal drugs which target cell integrity – an update. Expert Opinion on Drug Discovery 3:8, 931-943 Online publication date: 1-Aug-2008. Summary | Full Text | PDF (625 KB) | PDF Plus (590 KB) |
|





Author for correspondence
TOC Alert